These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2134507)

  • 21. [Dosage regimen optimization in cancer chemotherapy using a mathematical model].
    Barbolosi D; Freyer G; Ciccolini J; Iliadis A
    Bull Cancer; 2003 Feb; 90(2):167-75. PubMed ID: 12660135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimal control analysis of a cancer chemotherapy problem.
    Swan GW
    IMA J Math Appl Med Biol; 1987; 4(2):171-84. PubMed ID: 3503092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Escalating drug delivery in cancer chemotherapy: a review of concepts and practice--Part 1.
    Gurney H; Dodwell D; Thatcher N; Tattersall MH
    Ann Oncol; 1993 Jan; 4(1):23-34. PubMed ID: 8435358
    [No Abstract]   [Full Text] [Related]  

  • 24. A mathematical model of periodically pulsed chemotherapy: tumor recurrence and metastasis in a competitive environment.
    Panetta JC
    Bull Math Biol; 1996 May; 58(3):425-47. PubMed ID: 8688836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new optimization based approach to experimental combination chemotherapy.
    Pereira FL; Pedreira CE; de Sousa JB
    Front Med Biol Eng; 1995; 6(4):257-68. PubMed ID: 7612501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of tumours on normal cells and optimal chemotherapy regimens: the case of several drugs and toxicity constraints.
    Matveev AS; Savkin AV
    Math Med Biol; 2005 Jun; 22(2):143-62. PubMed ID: 15781427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal control for selected cancer chemotherapy ODE models: a view on the potential of optimal schedules and choice of objective function.
    Engelhart M; Lebiedz D; Sager S
    Math Biosci; 2011 Jan; 229(1):123-34. PubMed ID: 21129386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapy burden, drug resistance, and optimal treatment regimen for cancer chemotherapy.
    Boldrini JL; Costa MI
    IMA J Math Appl Med Biol; 2000 Mar; 17(1):33-51. PubMed ID: 10757031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotherapeutic treatments: a study of the interplay among drug resistance, toxicity and recuperation from side effects.
    Costa MI; Boldrini JL
    Bull Math Biol; 1997 Mar; 59(2):205-32. PubMed ID: 9116600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of heterogeneity on optimal regimens in cancer chemotherapy.
    Murray JM; Coldman AJ
    Math Biosci; 2003 Sep; 185(1):73-87. PubMed ID: 12900142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal control of a mathematical model for cancer chemotherapy under tumor heterogeneity.
    Wang S; Schattler H
    Math Biosci Eng; 2016 Dec; 13(6):1223-1240. PubMed ID: 27775377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On mathematical modeling of critical variables in cancer treatment (goals: better understanding of the past and better planning in the future).
    Skipper HE
    Bull Math Biol; 1986; 48(3-4):253-78. PubMed ID: 3828557
    [No Abstract]   [Full Text] [Related]  

  • 33. Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis.
    Ledzewicz U; Schättler H
    J Theor Biol; 2008 May; 252(2):295-312. PubMed ID: 18371982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug scheduling of cancer chemotherapy based on natural actor-critic approach.
    Ahn I; Park J
    Biosystems; 2011 Nov; 106(2-3):121-9. PubMed ID: 21839140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal chemical control of populations developing drug resistance.
    Costa MI; Boldrini JL; Bassanezi RC
    IMA J Math Appl Med Biol; 1992; 9(3):215-26. PubMed ID: 1295929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The dynamics of cell proliferation.
    Moxnes JF; Haux J; Hausken K
    Med Hypotheses; 2004; 62(4):556-63. PubMed ID: 15050107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-objective optimal chemotherapy control model for cancer treatment.
    Algoul S; Alam MS; Hossain MA; Majumder MA
    Med Biol Eng Comput; 2011 Jan; 49(1):51-65. PubMed ID: 20886373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal control of tumor size used to maximize survival time when cells are resistant to chemotherapy.
    Martin RB; Fisher ME; Minchin RF; Teo KL
    Math Biosci; 1992 Jul; 110(2):201-19. PubMed ID: 1498450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A bilinear control model for tumor growth and chemotherapy.
    Vaidya VG; Alexandro FJ; Vaidya PG
    Int J Biomed Comput; 1985 Sep; 17(2):145-54. PubMed ID: 4055120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modeling oxaliplatin drug delivery to circadian rhythms in drug metabolism and host tolerance.
    Clairambault J
    Adv Drug Deliv Rev; 2007 Aug; 59(9-10):1054-68. PubMed ID: 17707544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.